Dr Tonny Veenith
Consultant in Neuro-critical Care and Critical Care Medicine at UHB, Senior Lecturer in University of Birmingham and Chief Investigator
“I am proud that Birmingham is leading the fight against COVID-19 with a trial to develop new therapeutic options. CATALYST is a fantastic example where the frontline clinicians, basic scientists and trial methodologists have worked tirelessly to develop evidence-based treatment options for COVID.”
The National Institute for Health Research (NIHR) has released information concerning the risk of COVID-19 in minority ethnic groups – see here for community response videos (available in a range of languages).